Gilead Sciences (GILD) Cash & Current Investments (2009 - 2026)
Gilead Sciences (GILD) recorded Cash & Current Investments of $3.18 billion in Q2 2026, down 39.0% from $5.21 billion a year earlier and down 58.4% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Cash & Current Investments (2009 - 2026) Analysis & Trends
At the end of FY2025, Gilead Sciences reported Cash & Current Investments of $7.63 billion, down 23.6% from FY2024.
- Annual Cash & Current Investments has a five-year compound annual growth rate of 0.6% (FY2020 to FY2025).
- Across earlier years, Cash & Current Investments came in at $9.99 billion in FY2024 (+37.5%), $7.26 billion in FY2023 (+13.8%), $6.39 billion in FY2022 (-2.1%) and $6.52 billion in FY2021 (-12.0%).
- The Q2 2026 figure is the lowest quarterly Cash & Current Investments since Q2 2024.
- On a year-over-year basis, Cash & Current Investments has declined for three consecutive quarters, with growth averaging 18.3% over the last eight quarters.
- Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 88.1% in Q2 2025, against a decline of 76.1% in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $7.64 billion (Q1 2026), $7.63 billion (Q4 2025) and $7.35 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | 7.85 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.18 Bn |
| Mar 31, 2026 | 7.64 Bn |
| Dec 31, 2025 | 7.63 Bn |
| Sep 30, 2025 | 7.35 Bn |
| Jun 30, 2025 | 5.21 Bn |
| Mar 31, 2025 | 7.93 Bn |
| Dec 31, 2024 | 9.99 Bn |
| Sep 30, 2024 | 5.04 Bn |
| Jun 30, 2024 | 2.77 Bn |
| Mar 31, 2024 | 4.72 Bn |
| Dec 31, 2023 | 7.26 Bn |
| Sep 30, 2023 | 6.86 Bn |
| Jun 30, 2023 | 6.67 Bn |
| Mar 31, 2023 | 5.87 Bn |
| Dec 31, 2022 | 6.39 Bn |
| Sep 30, 2022 | 5.66 Bn |
| Jun 30, 2022 | 5.66 Bn |
| Mar 31, 2022 | 5.33 Bn |
| Dec 31, 2021 | 6.52 Bn |
| Sep 30, 2021 | 5.74 Bn |
API Access
Gilead Sciences Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();